Smaller CROs May Do It Better, Quicker – Especially in Times of Crisis
Pursuit of a path from discovery to drug approval as quickly as possible is a clear objective for most biotech…
Recommendations for Quicker CTA Negotiation
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…
Oncology Trial Investigators and Participants – Where to Look?
Global Leaders in Number of Clinical Trial Participants Today Clinical research is becoming more complex, with more clinical trials than…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
Real World Evidence of a Successful Oncology Trial Rescue in Canada
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…
How Does Your CRO’s Feasibility Process Contribute to Your Clinical Trial Success?
In clinical research, the process of finding and selecting sites is essential to the success of a study, as it…
Canadian Know-How: Successfully Navigating a Centralized Framework for Oncology Clinical Trial Ethical Review
Now more than ever, time is of the essence when it comes to oncology clinical trial start-up and execution. The…
Canada: a Region of Choice for Your Study Expansion
Successfully designing and conducting oncology trials is not getting easier. Many of the challenges we are facing in oncology research…
Why Does Your CRO’s Assignment Practice for CRAs Matter?
Monitoring the progress of the research represents a fundamental aspect of successful outcomes by ensuring that constraints to success are…
Exploring a ‘Rescue’ Strategy for Your Oncology Clinical Trial?
Although not formally defined within the industry, the term ‘rescue’ is commonly linked with clinical trials where enrollment is falling…